PMC:7205724 / 21667-21784 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"739","span":{"begin":0,"end":4},"obj":"Gene"},{"id":"741","span":{"begin":87,"end":88},"obj":"Gene"}],"attributes":[{"id":"A739","pred":"tao:has_database_id","subj":"739","obj":"Gene:59272"},{"id":"A741","pred":"tao:has_database_id","subj":"741","obj":"Gene:43740568"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ACE2 receptor [26]. By contrast, neutralizing antibodies that specifically target SARS-S could compete with S1B and S"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T163","span":{"begin":82,"end":86},"obj":"Disease"}],"attributes":[{"id":"A163","pred":"mondo_id","subj":"T163","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"ACE2 receptor [26]. By contrast, neutralizing antibodies that specifically target SARS-S could compete with S1B and S"}

{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T21","span":{"begin":33,"end":56},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A21","pred":"meddra_id","subj":"T21","obj":"http://purl.bioontology.org/ontology/MEDDRA/10058063"}],"text":"ACE2 receptor [26]. By contrast, neutralizing antibodies that specifically target SARS-S could compete with S1B and S"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T215","span":{"begin":82,"end":86},"obj":"Species"}],"attributes":[{"id":"A215","pred":"ncbi_taxonomy_id","subj":"T215","obj":"NCBItxid:694009"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"ACE2 receptor [26]. By contrast, neutralizing antibodies that specifically target SARS-S could compete with S1B and S"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"739","span":{"begin":0,"end":4},"obj":"Gene"},{"id":"741","span":{"begin":87,"end":88},"obj":"Gene"}],"attributes":[{"id":"A739","pred":"pubann:denotes","subj":"739","obj":"Gene:59272"},{"id":"A741","pred":"pubann:denotes","subj":"741","obj":"Gene:43740568"}],"text":"ACE2 receptor [26]. By contrast, neutralizing antibodies that specifically target SARS-S could compete with S1B and S"}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T2072","span":{"begin":108,"end":111},"obj":"Protein"}],"attributes":[{"id":"A2072","pred":"uniprot_id","subj":"T2072","obj":"https://www.uniprot.org/uniprot/P47835"}],"text":"ACE2 receptor [26]. By contrast, neutralizing antibodies that specifically target SARS-S could compete with S1B and S"}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T80580","span":{"begin":0,"end":4},"obj":"NN"},{"id":"T18877","span":{"begin":5,"end":13},"obj":"NN"},{"id":"T18503","span":{"begin":14,"end":15},"obj":"-LRB-"},{"id":"T33177","span":{"begin":15,"end":17},"obj":"CD"},{"id":"T92006","span":{"begin":17,"end":18},"obj":"-RRB-"},{"id":"T53652","span":{"begin":20,"end":22},"obj":"IN"},{"id":"T58622","span":{"begin":23,"end":31},"obj":"NN"},{"id":"T35381","span":{"begin":31,"end":32},"obj":"-COMMA-"},{"id":"T41843","span":{"begin":33,"end":45},"obj":"VBG"},{"id":"T81589","span":{"begin":46,"end":56},"obj":"NNS"},{"id":"T68196","span":{"begin":57,"end":61},"obj":"WDT"},{"id":"T30816","span":{"begin":62,"end":74},"obj":"RB"},{"id":"T53446","span":{"begin":75,"end":81},"obj":"NN"},{"id":"T89813","span":{"begin":82,"end":88},"obj":"NN"},{"id":"T95236","span":{"begin":89,"end":94},"obj":"MD"},{"id":"T7888","span":{"begin":95,"end":102},"obj":"VB"},{"id":"T34125","span":{"begin":103,"end":107},"obj":"IN"},{"id":"T82101","span":{"begin":108,"end":111},"obj":"NN"},{"id":"T1902","span":{"begin":112,"end":115},"obj":"CC"}],"relations":[{"id":"R37042","pred":"arg1Of","subj":"T18877","obj":"T80580"},{"id":"R82088","pred":"arg1Of","subj":"T18877","obj":"T18503"},{"id":"R55576","pred":"arg2Of","subj":"T33177","obj":"T18503"},{"id":"R41077","pred":"arg3Of","subj":"T92006","obj":"T18503"},{"id":"R68866","pred":"arg1Of","subj":"T41843","obj":"T53652"},{"id":"R80894","pred":"arg2Of","subj":"T58622","obj":"T53652"},{"id":"R42535","pred":"arg1Of","subj":"T41843","obj":"T35381"},{"id":"R99048","pred":"arg1Of","subj":"T81589","obj":"T41843"},{"id":"R45757","pred":"arg1Of","subj":"T81589","obj":"T68196"},{"id":"R2391","pred":"arg1Of","subj":"T7888","obj":"T30816"},{"id":"R14961","pred":"arg1Of","subj":"T89813","obj":"T53446"},{"id":"R96775","pred":"arg1Of","subj":"T89813","obj":"T95236"},{"id":"R6780","pred":"arg2Of","subj":"T7888","obj":"T95236"},{"id":"R40504","pred":"arg1Of","subj":"T89813","obj":"T7888"},{"id":"R84230","pred":"arg2Of","subj":"T81589","obj":"T7888"},{"id":"R48027","pred":"arg1Of","subj":"T7888","obj":"T34125"},{"id":"R59163","pred":"arg2Of","subj":"T1902","obj":"T34125"},{"id":"R39175","pred":"arg1Of","subj":"T82101","obj":"T1902"}],"text":"ACE2 receptor [26]. By contrast, neutralizing antibodies that specifically target SARS-S could compete with S1B and S"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T158","span":{"begin":82,"end":86},"obj":"Disease"}],"attributes":[{"id":"A158","pred":"mondo_id","subj":"T158","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"ACE2 receptor [26]. By contrast, neutralizing antibodies that specifically target SARS-S could compete with S1B and S"}